Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of 24.23x is 173% above its 3-year average of 8.89x, near the high end of its 3-year range (-248.77x–48.88x).
14.15% below its 12-month average of 28.22x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): 48.88x.
INTEREST COVERAGE RATIO
24.23x
INTEREST COVERAGE RATIO AVG TTM
28.22x
INTEREST COVERAGE RATIO AVG 3Y
8.89x
INTEREST COVERAGE RATIO AVG 5Y
8.89x
INTEREST COVERAGE RATIO AVG 10Y
-12.58x
INTEREST COVERAGE RATIO AVG 15Y
-29.68x
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-14.15%
CURRENT VS 3Y AVG
+172.60%
CURRENT VS 5Y AVG
+172.60%
CURRENT VS 10Y AVG
+292.56%
CURRENT VS 15Y AVG
+181.63%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.23x
median of 360 covered companies
CURRENT VS SECTOR MEDIAN
+672.81%
vs the sector median at left
Aurinia Pharmaceuticals Inc.
Market Cap
$2.00B
Interest Coverage Ratio
24.23x
TTM Avg
28.22x
3Y Avg
8.89x
5Y Avg
8.89x
Market Cap
$2.01B
Interest Coverage Ratio
371.93x
TTM Avg
1006.04x
3Y Avg
1006.04x
5Y Avg
1006.04x
Market Cap
$2.00B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.02B
Interest Coverage Ratio
-1.02x
TTM Avg
0.38x
3Y Avg
0.38x
5Y Avg
0.21x
Market Cap
$2.03B
Interest Coverage Ratio
N/A
TTM Avg
1.77x
3Y Avg
2.62x
5Y Avg
35.29x
Market Cap
$2.03B
Interest Coverage Ratio
4.32x
TTM Avg
4.32x
3Y Avg
4.32x
5Y Avg
4.32x
Market Cap
$1.94B
Interest Coverage Ratio
-1.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.00B | 24.23x | 28.22x | 8.89x | 8.89x |
| Inspire Medical Systems, Inc. (INSP)vs › | $2.01B | 371.93x | 1006.04x | 1006.04x | 1006.04x |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $2.00B | N/A | N/A | N/A | N/A |
| AxoGen, Inc. (AXGN)vs › | $2.02B | -1.02x | 0.38x | 0.38x | 0.21x |
| Azenta, Inc. (AZTA)vs › | $2.03B | N/A | 1.77x | 2.62x | 35.29x |
| Immunome, Inc. (IMNM)vs › | $1.98B | N/A | N/A | N/A | N/A |
| BioCryst Pharmaceuticals, Inc. (BCRX)vs › | $2.03B | 4.32x | 4.32x | 4.32x | 4.32x |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.94B | -1.54x | N/A | N/A | N/A |
| Alvotech (ALVO)vs › | $2.07B | 0.52x | 0.48x | 0.48x | 0.48x |
| Addus HomeCare Corporation (ADUS)vs › | $2.10B | 14.46x | 13.87x | 10.91x | 11.49x |
Interest Coverage
24.2x
Debt/Equity
0.10
Current Ratio
5.42
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | 48.88x |
| 2026-03-31 | 40.93x |
| 2025-12-31 | 5.10x |
| 2025-06-30 | 17.98x |
| 2025-03-31 | 20.48x |
| 2024-12-31 | -1.46x |
| 2024-09-30 | 9.73x |
| 2024-06-30 | -1.26x |
| 2024-03-31 | -8.34x |
| 2023-12-31 | -22.65x |
| 2023-09-30 | -11.62x |
| 2023-06-30 | -248.77x |
| 2019-12-31 | -2322.22x |
| 2019-09-30 | -2667.89x |
| 2019-06-30 | -1645.40x |
| 2019-03-31 | -1353.18x |
| 2014-03-31 | -124.10x |
| 2013-12-31 | -48.54x |
| 2013-09-30 | -42.00x |
| 2013-06-30 | -38.00x |
| 2013-03-31 | -33.24x |
| 2012-12-31 | -185.17x |
| 2012-09-30 | -61.63x |
| 2012-06-30 | -1943.00x |
| 2012-03-31 | 90.00x |
| 2011-12-31 | -1912.25x |
| 2010-12-31 | 308.67x |
| 2010-09-30 | -207.43x |
| 2010-06-30 | -646.00x |
| 2009-12-31 | -81.53x |
| 2009-06-30 | -11.97x |
| 2009-03-31 | -3.84x |
